Llew Keltner, Director at Raptor Pharmaceutical Corp (RPTP), bought 100 shares at $8.37 ($837) on 2014-05-30, disclosed to the SEC on 2014-06-03.
Open-market purchase of $837 RPTP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| RPTP | SELL | 2014-03-11 | $157K | — | Filing → |
| RPTP | SELL | 2014-01-09 | $133K | — | Filing → |
| RPTP | SELL | 2013-11-12 | $140K | — | Filing → |